|Articles|November 9, 2021
- Pharmaceutical Executive-11-01-2021
- Volume 41
- Issue 11
Pharmaceutical Executive, November 2021 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2021 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 4 years ago
In It For the Long-Haul: Planning for the Future of COVID-19over 4 years ago
Turning the Corner: A New Era of Pharma Sales Comes Into Viewover 4 years ago
The New COVID Workforce: Keeping Pharma Strong Through Adversityover 4 years ago
Crafting Curesover 4 years ago
Could 2022 Prove to Be Better Year for Biotech Companies?over 4 years ago
COVID and the Data Talent Turnaboutover 4 years ago
EU MEPs Arrive At Crossroads in Cancer Strategyover 4 years ago
Pharm Exec at 40 (2015-2018)Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5

